Avrobio Inc reported $-28054000 in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Akebia Therapeutics AKBA:US USD -51865000 81.14M
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Bluebird Bio BLUE:US USD -76520000 23.62M
Gilead Sciences GILD:US USD 1.79B 645M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
Karyopharm Therapeutics KPTI:US USD -36324000 12.74M
Macrogenics MGNX:US USD -24813000 16.49M
Pfizer PFE:US USD 8.61B 1.3B
Roche Holding ROG:VX 8.53B 2.4B
Sangamo Biosciences SGMO:US USD -53155000 9.98M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
Takeda 4502:JP JPY 61.74B 43.27B